And other news from Christians around the world.

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other stocks Jim Cramer talked about. Jim Cramer, host of Mad Money, recently shared ...

Gilead’s strong fundamentals make it a good biotech stock to buy and hold for the long term. At current levels, we believe there is more room for growth. The company’s attractive dividend ...

President Claudia Sheinbaum used her morning news briefing to present the song “Migrant Hymn.” The lyrics, a mix of English and Spanish, include lines like “where we are from, no nos rajamos” (we ...

You’ll never need another lip balm again after you try e.l.f.’s Hydrating ... Image Courtesy of e.l.f. via Amazon. There’s a lot to love about e.l.f.’s Hydrating Core Lip Shine, including ...

Gilead's stock has surged due to successful launches of Livdelzi for PBC and promising developments in lenacapavir for HIV prevention. Livdelzi's approval and strong market potential, combined ...

If you’re on the fence about investing in Natera, Inc., Gilead Sciences or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision ...

If you’re on the fence about investing in Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before ...

Details are thin on the ground, but we know Gilead is tapping into Terray’s so-called tNova platform, the startup’s generative AI. This platform is designed to improve the speed, cost and ...

-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- FOSTER CITY, Calif. & LOS ANGELES--(BUSINESS WIRE ...

Gilead Sciences (GILD ... usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision ...